Literature DB >> 25584159

Clinical presentation, management, and outcome of patients with incidental renal angiomyolipoma in qatar.

Hassan Al-Thani1, Ayman El-Menyar2, Maryam Al-Sulaiti1, Jamela El-Mabrok1, Khairi Hajaji1, Hesham Elgohary1, Ahmed Al-Malki1, Abdelhakem Tabeb1.   

Abstract

OBJECTIVES: Our study aimed to analyze the clinical presentation, management, and outcome of renal angiomyolipoma patients incidentally detected upon computed tomography (CT) examination.
METHODS: Between 2004 and 2008, all patients who underwent abdominal CT examination for any reason at the radiology department at Hamad General Hospital, Qatar were retrospectively reviewed. The diagnosis of renal angiomyolipoma was based on abdominal CT evaluation. Angiomyolipoma patients were followed-up by CT evaluation as per standard care for three years to observe any change in size and outcome.
RESULTS: A total of 13,115 patients were screened, of which 56 (40 females and 16 males) had renal angiomyolipoma. The mean age of patients was 52±13 years with 46% Qatar nationals. The majority (95%) of cases had unilateral tumors (52% right-sided and 43% left-sided). Twenty-six cases showed increase in tumor size and the median increase was 0.5cm (0.1-3.6). Surgical intervention was required in four (7%) cases with tumor size ≥4cm. The overall mortality on follow-up was 7%. The cause of death included metastasis, renal failure, hepatic failure and mesenteric thromboembolism.
CONCLUSION: Renal angiomyolipoma is an uncommon benign tumor with an overall prevalence of 0.4% in Qatar. It has characteristic clinical features and its recognition is often challenging for proper clinical diagnosis and treatment in asymptomatic patients. Asymptomatic patients need regular radiological surveillance. In contrast, surgical interventions are mainly required in symptomatic patients with increased tumor size (≥4cm). Timely diagnosis and treatment is necessary to avoid complications such retroperitoneal hemorrhage and renal impairment.

Entities:  

Keywords:  Incidental CT finding; Renal angiomyolipoma; Renal tumor

Year:  2014        PMID: 25584159      PMCID: PMC4289492          DOI: 10.5001/omj.2014.112

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  26 in total

Review 1.  Mesenchymal neoplasms of the kidney in adults: imaging spectrum with radiologic-pathologic correlation.

Authors:  Venkata S Katabathina; Raghunandan Vikram; Arpit M Nagar; Pheroze Tamboli; Christine O Menias; Srinivasa R Prasad
Journal:  Radiographics       Date:  2010-10       Impact factor: 5.333

2.  Renal metastases from thyroid cancer masquerading as renal angiomyolipoma on ultrasonography.

Authors:  Mohammed Ahmed; Muhammad Aslam; Javed Ahmed; Haroon Ahmed Faraz; Abdulraof Almahfouz; Abdullah Al Arifi; Hussein Raef; Fouad Al Dayel
Journal:  J Ultrasound Med       Date:  2006-11       Impact factor: 2.153

3.  Changing trends in presentation, diagnosis and management of renal angiomyolipoma: comparison of sporadic and tuberous sclerosis complex-associated forms.

Authors:  Raouf M Seyam; Nabil K Bissada; Said A Kattan; Alaa A Mokhtar; Muhammad Aslam; Wahib E Fahmy; Walid A Mourad; Ali A Binmahfouz; Hassan M Alzahrani; Kamal A Hanash
Journal:  Urology       Date:  2008-09-21       Impact factor: 2.649

4.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

5.  Incidental angiomyolipoma resected during renal surgery for an enhancing renal mass.

Authors:  Ryan K Berglund; Melanie Bernstein; Martin T Manion; Karim A Touijer; Paul Russo
Journal:  BJU Int       Date:  2009-06-10       Impact factor: 5.588

6.  FDG PET or PET/CT in evaluation of renal angiomyolipoma.

Authors:  Chun-Yi Lin; Hui-Yi Chen; Hueisch-Jy Ding; Kuo-Yang Yen; Chia-Hung Kao
Journal:  Korean J Radiol       Date:  2013-02-22       Impact factor: 3.500

7.  Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture.

Authors:  Koichiro Yamakado; Naoshi Tanaka; Toshio Nakagawa; Shigeki Kobayashi; Makoto Yanagawa; Kan Takeda
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

8.  Angiomyolipoma of the kidney: clinicopathological and immunohistochemical study.

Authors:  Ghada El Sayed Esheba; Noha El Sayed Esheba
Journal:  J Egypt Natl Canc Inst       Date:  2013-06-10

Review 9.  Giant renal artery pseudoaneurysm caused by rupture of renal angiomyolipoma following pregnancy: endovascular treatment and review of the literature.

Authors:  Ilkay S Idilman; Sanela Vesnic; Barbaras Cil; Bora Peynircioglu
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-03

10.  Prevalence of sporadic renal angiomyolipoma: a retrospective analysis of 61,389 in- and out-patients.

Authors:  Astrid Fittschen; Inka Wendlik; Suemeyra Oeztuerk; Wolfgang Kratzer; Atilla S Akinli; Mark M Haenle; Tilmann Graeter
Journal:  Abdom Imaging       Date:  2014-10
View more
  3 in total

1.  Surveillance imaging for sporadic renal angiomyolipoma less than 40 mm: lessons learnt and recommendations from the experience of a large district general hospital.

Authors:  K E Chan; Ecp Chedgy; C L Bent; K J Turner
Journal:  Ann R Coll Surg Engl       Date:  2018-04-16       Impact factor: 1.891

Review 2.  Active Surveillance for Renal Angiomyolipoma Less Than 4 Centimeters: A Systematic Review of Cohort Studies.

Authors:  Mohamed Zeid; Hani Sayedin; Nauman Nabi; Mamoun Abdelrahman; Prem Thomas Jacob; Bassem Alhadi; Subhasis Giri
Journal:  Cureus       Date:  2022-02-28

3.  Factors associated with the number and size of renal angiomyolipomas in sporadic angiomyolipoma (sAML): a study of adult patients with sAML managed in a Dutch tertiary referral center.

Authors:  J L H Ruud Bosch; Francis Vekeman; Mei Sheng Duh; Maureen Neary; Matthew Magestro; Jonathan Fortier; Paul Karner; Raluca Ionescu-Ittu; Bernard A Zonnenberg
Journal:  Int Urol Nephrol       Date:  2018-01-15       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.